About Senestech Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://senestech.com/
Frequently Asked Questions
What is the 52-week range for SNES?
The 52-week high is $4.45 and the 52-week low is $0.6251.
What is the P/E ratio for SNES?
The P/E ratio data is currently unavailable.
What is the dividend yield for SNES?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -80.73%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -294.73%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.16.
Analyst Recommendation Trends
Wall Street analyst consensus for SNES over the last few months:
Latest SNES News
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's after-market session. The market value of their outstanding shares is at $276.0 million. Stablecoin Development
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-market session. The company's market cap stands at $1.3 million. Summit Therapeutics (NASDAQ:SMMT) stock rose 16.34%
SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers
SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Evolve® family of rodent birth control products will soon be available through Grove Collaborative's online marketplace. The launch will expand consumer access to an innovative rodent control solution for environmentally conscious households.
SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference
SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after-market session. The company's market cap stands at $11.5 million. Picard Medical (AMEX:PMI) stock moved upwards
CEO Chat with Michael Edell, President and CEO of SenesTech, Inc.
NASDAQ: SNES Richard Hantke: Hello everyone. My name is Richard Hantke with Zacks Small Cap Research , and welcome to another episode of our CEO Chat series. Today we've got SenesTech (NASDAQ: SNES), which is involved with rodent birth control solutions, which is kind of interesting. We'll get into that. Zacks has it under coverage with our analyst M. Marin. In her most recent report a few weeks
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-28 | Edell Michael | +2,000 | $0.6444 | $1,289 |
| 2026-09-14 | Edell Michael | +1,000 | $0.84 | $840 |
| 2026-09-09 | Edell Michael | +1,000 | $0.85 | $850 |
| 2026-09-09 | Edell Michael | +1,000 | $0.89 | $890 |
| 2026-08-14 | Edell Michael | +1,000 | $1.21 | $1,210 |
| 2026-08-07 | GLENBROOK CAPITAL MANAGEMENT | +6,490 | $1.2977 | $8,422 |
| 2026-08-06 | GLENBROOK CAPITAL MANAGEMENT | +15,000 | $1.2962 | $19,443 |
| 2026-07-20 | GLENBROOK CAPITAL MANAGEMENT | +35,000 | $1.4734 | $51,569 |
| 2026-07-07 | Edell Michael | +1,000 | $1.4299 | $1,430 |
| 2026-06-30 | GLENBROOK CAPITAL MANAGEMENT | +35,000 | $1.5066 | $52,731 |
| 2026-06-22 | GLENBROOK CAPITAL MANAGEMENT | +5,000 | $1.6591 | $8,296 |
| 2026-06-17 | GLENBROOK CAPITAL MANAGEMENT | +3,264 | $1.6139 | $5,268 |
| 2026-06-15 | Szot Matthew K | +100,000 | - | - |
| 2026-06-15 | CHESTERMAN THOMAS C | +75,000 | - | - |
| 2026-06-09 | Edell Michael | +263,288 | - | - |
| 2026-06-08 | Edell Michael | +1,000 | $1.55 | $1,550 |
| 2026-06-08 | GLENBROOK CAPITAL MANAGEMENT | +7,000 | $1.6148 | $11,304 |
| 2026-06-05 | GLENBROOK CAPITAL MANAGEMENT | +13,159 | $1.5719 | $20,685 |
| 2026-06-04 | GLENBROOK CAPITAL MANAGEMENT | +8,230 | $1.6461 | $13,547 |
| 2026-05-18 | GLENBROOK CAPITAL MANAGEMENT | +10,000 | $1.5878 | $15,878 |
| 2026-05-15 | Edell Michael | +1,000 | $1.615 | $1,615 |
| 2026-05-15 | GLENBROOK CAPITAL MANAGEMENT | +7,120 | $1.6498 | $11,747 |
| 2026-05-14 | Edell Michael | +2,000 | $1.6988 | $3,398 |
| 2026-05-14 | GLENBROOK CAPITAL MANAGEMENT | +15,000 | $1.7241 | $25,862 |
| 2026-04-28 | GLENBROOK CAPITAL MANAGEMENT | +3,000 | $1.469 | $4,407 |
| 2026-03-17 | GLENBROOK CAPITAL MANAGEMENT | +19,725 | $1.7924 | $35,355 |
| 2026-03-16 | GLENBROOK CAPITAL MANAGEMENT | +5,060 | $1.8562 | $9,392 |
| 2026-03-13 | GLENBROOK CAPITAL MANAGEMENT | +146,249 | $1.9517 | $285,434 |
| 2026-02-19 | GLENBROOK CAPITAL MANAGEMENT | +34,613 | $2.402 | $83,140 |
| 2026-02-18 | GLENBROOK CAPITAL MANAGEMENT | +10,481 | $2.29 | $24,001 |
| 2026-02-17 | GLENBROOK CAPITAL MANAGEMENT | +40,807 | $2.2911 | $93,493 |
| 2026-02-13 | GLENBROOK CAPITAL MANAGEMENT | +15,390 | $1.8912 | $29,106 |
| 2026-02-12 | GLENBROOK CAPITAL MANAGEMENT | +7,956 | $1.7205 | $13,688 |
| 2026-02-11 | GLENBROOK CAPITAL MANAGEMENT | +8,000 | $1.7342 | $13,874 |
| 2026-02-05 | GLENBROOK CAPITAL MANAGEMENT | +2,884 | $1.7705 | $5,106 |
| 2026-02-04 | GLENBROOK CAPITAL MANAGEMENT | +5,685 | $1.8247 | $10,373 |
| 2026-02-02 | GLENBROOK CAPITAL MANAGEMENT | +42,739 | $1.9752 | $84,418 |
| 2026-01-30 | GLENBROOK CAPITAL MANAGEMENT | +5,399 | $1.8718 | $10,106 |
| 2025-11-18 | Leach Jacob Steven | -62 | $2.71 | $168 |
| 2025-11-14 | Szot Matthew K | -1 | $2.75 | $3 |